MicroTech Medical returns to profit in H1 FY26, net profit RMB 40.27 million; revenue rises 68.4% to RMB 414.14 million

PUBT · 2d ago
MicroTech Medical returns to profit in H1 FY26, net profit RMB 40.27 million; revenue rises 68.4% to RMB 414.14 million
  • MicroTech Medical posted revenue of RMB 414.14 million, up 68.4% year over year.
  • Net profit swung to RMB 40.27 million from a loss a year earlier; basic EPS was RMB 0.10.
  • Gross margin widened 6 percentage points to 57.7%.
  • CGMS revenue more than doubled to RMB 313.02 million, driven by faster domestic and international sales.
  • LinX S1 received EU CE marking in April 2026; second-generation patch insulin pump won China NMPA adult approval in July 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MicroTech Medical Hangzhou Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12294928), on August 21, 2026, and is solely responsible for the information contained therein.